Cartesian Therapeutics, Inc. — Director's Dealing 2019

Jun 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-06-14

Reporting Person: Myers Scott Dunseth (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-14	Stock Option (Right to Buy)	$2.1	A	20000	Acquired	2029-06-13	Common Stock (20000.0)	Direct

Footnotes

F1: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.